Denise Baez - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Denise Baez's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Denise Baez

Denise Baez

Verified

Managing Editor and Director, PSL Group, DocGuide

Franklin Square

Final Covers

Fitness, Mental health, Health Advice , Nutrition , Wellness Trends , Exercise, Health Advice , Nutrition , Wellness Trends , Exercise, New Research , Studies , Health News

Doesn’t Cover

Fashion, Beauty

Journalist Type

Seniority Positions

Industries

-

Medium Formats

Content

Total articles 48

  • Considerable Escape of SARS-CoV-2 Omicron to Antibody Neutralisation

    By Denise Baez Verified| DocGuide Verified Source: DGNews  |  Posted 1 week agoConsiderable Escape of SARS-CoV-2 Omicron to Antibody NeutralisationBy Denise BaezThe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant appears to escape most therapeutic monoclonal antibodies and, to a large extent, vaccine-elicited antibodies, according to a study published in Nature.

    By Denise Baez Verified · DocGuide

    Jan. 21, 2022

  • Booster dose of BNT162b2 vaccine significantly lowers rate of SARS-CoV-2 infection in real-world study, but ongoing surveillance is needed

    By Denise Baez Verified| DocGuide Verified By Denise BaezNEW YORK -- January 11, 2022 -- Among healthcare workers at a single centre in Israel who were previously vaccinated with a 2-dose series of the Pfizer-BioNTech BNT162b2 coronavirus disease 2019 (COVID-19) vaccine, administration of a booster dose, compared with not receiving one, was associated with a significantly lower rate of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection over a median of 39 days of follow-up, according to a study published in JAMA.

    By Denise Baez Verified · DocGuide

    Jan. 11, 2022

  • Considerable Escape of SARS-CoV-2 Omicron to Antibody Neutralisation

    By Denise Baez Verified| DocGuide Verified Source: DGNews  |  Posted 1 week agoConsiderable Escape of SARS-CoV-2 Omicron to Antibody NeutralisationBy Denise BaezThe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant appears to escape most therapeutic monoclonal antibodies and, to a large extent, vaccine-elicited antibodies, according to a study published in Nature.

    By Denise Baez Verified · DocGuide

    Jan. 21, 2022

As seen in

Company Info

DocGuide